JPMorgan Chase & Co. Acquires 37,032 Shares of Arteris, Inc. (NASDAQ:AIP)

JPMorgan Chase & Co. raised its stake in Arteris, Inc. (NASDAQ:AIP - Free Report) by 67.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 92,242 shares of the company's stock after buying an additional 37,032 shares during the period. JPMorgan Chase & Co. owned 0.23% of Arteris worth $712,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. US Bancorp DE bought a new position in Arteris during the 3rd quarter worth approximately $34,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris during the second quarter worth $86,000. Algert Global LLC bought a new position in Arteris during the second quarter worth $115,000. MetLife Investment Management LLC lifted its holdings in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock valued at $131,000 after buying an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Arteris during the third quarter valued at $226,000. Institutional investors own 64.36% of the company's stock.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reissued a "buy" rating and issued a $15.00 price target on shares of Arteris in a research note on Wednesday, November 6th.

Insider Activity

In other Arteris news, CFO Nicholas B. Hawkins sold 19,299 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total transaction of $157,093.86. Following the completion of the transaction, the chief financial officer now directly owns 192,414 shares of the company's stock, valued at approximately $1,566,249.96. This represents a 9.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Isabelle F. Geday sold 15,550 shares of the firm's stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $9.03, for a total value of $140,416.50. Following the completion of the sale, the director now directly owns 121,213 shares of the company's stock, valued at $1,094,553.39. This represents a 11.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 325,456 shares of company stock valued at $3,355,352 in the last ninety days. 33.70% of the stock is currently owned by insiders.

Arteris Stock Down 14.5 %

AIP stock traded down $1.74 during trading on Monday, reaching $10.30. The stock had a trading volume of 412,481 shares, compared to its average volume of 385,859. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $413.82 million, a price-to-earnings ratio of -10.73 and a beta of 1.17. Arteris, Inc. has a one year low of $5.76 and a one year high of $12.64. The company's 50 day moving average is $10.07 and its two-hundred day moving average is $8.49.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.